Free Trial
CVE:BRM

BioRem (BRM) Stock Price, News & Analysis

BioRem logo
C$2.80 -0.07 (-2.44%)
As of 01:22 PM Eastern

About BioRem Stock (CVE:BRM)

Key Stats

Today's Range
C$2.80
C$2.86
50-Day Range
C$2.46
C$3.35
52-Week Range
C$1.37
C$3.45
Volume
7,292 shs
Average Volume
51,943 shs
Market Capitalization
C$45.91 million
P/E Ratio
8.65
Dividend Yield
6.47%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.

Receive BRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter.

BRM Stock News Headlines

Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself. Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit. Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too.
BRM:CA Stock Price
BioRem Inc. (BRM.V)
See More Headlines

BRM Stock Analysis - Frequently Asked Questions

BioRem's stock was trading at C$3.05 at the beginning of the year. Since then, BRM shares have decreased by 8.2% and is now trading at C$2.80.
View the best growth stocks for 2025 here
.

BioRem Inc. (CVE:BRM) released its quarterly earnings data on Wednesday, November, 6th. The company reported $0.12 earnings per share (EPS) for the quarter. BioRem had a trailing twelve-month return on equity of 65.14% and a net margin of 12.91%.

Shares of BRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioRem investors own include TVA Group (TVA.B), Questor Technology (QST), AutoZone (AZO), Cadence Design Systems (CDNS), FormFactor (FORM), Intel (INTC) and K92 Mining Inc. (KNT.V) (KNT).

Company Calendar

Last Earnings
11/06/2024
Today
2/20/2025

Industry, Sector and Symbol

Industry
Pollution & Treatment Controls
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
34,300
Year Founded
N/A

Profitability

Net Income
C$5.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$41.84 million
Cash Flow
C$0.78 per share
Book Value
C$0.63 per share

Miscellaneous

Free Float
N/A
Market Cap
C$47.06 million
Optionable
Not Optionable
Beta
0.85
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (CVE:BRM) was last updated on 2/20/2025 by MarketBeat.com Staff
From Our Partners